HBZ and metastatic neoplasm: We thus demonstrated for the first time in an animal model, that the HTLV-1 oncogene HBZ might have an important role in ATL-mediated bone loss independent of Tax and suggest that HBZ-mediated bone loss may respond to current therapies for bone resident and metastatic tumors.